NEXGEL, Inc. (NASDAQ:NXGL – Get Free Report) CEO Adam R. Levy sold 4,000 shares of the company’s stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $3.64, for a total value of $14,560.00. Following the completion of the transaction, the chief executive officer now directly owns 378,284 shares in the company, valued at $1,376,953.76. This trade represents a 1.05 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.
NEXGEL Stock Down 0.0 %
NXGL stock traded down $0.00 during midday trading on Wednesday, hitting $3.54. The company’s stock had a trading volume of 16,552 shares, compared to its average volume of 122,685. The company has a market cap of $24.03 million, a PE ratio of -6.10 and a beta of 0.57. NEXGEL, Inc. has a 12 month low of $1.84 and a 12 month high of $5.10. The company has a current ratio of 1.51, a quick ratio of 0.93 and a debt-to-equity ratio of 0.19. The firm’s 50-day moving average is $3.85 and its 200-day moving average is $3.19.
Hedge Funds Weigh In On NEXGEL
An institutional investor recently bought a new position in NEXGEL stock. IFP Advisors Inc acquired a new position in NEXGEL, Inc. (NASDAQ:NXGL – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 11,000 shares of the company’s stock, valued at approximately $49,000. IFP Advisors Inc owned approximately 0.16% of NEXGEL at the end of the most recent reporting period. Institutional investors and hedge funds own 2.21% of the company’s stock.
About NEXGEL
NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.
Featured Stories
- Five stocks we like better than NEXGEL
- What Do S&P 500 Stocks Tell Investors About the Market?
- 3 Must-Have ETFs Set to Dominate This Quarter
- Options Trading – Understanding Strike Price
- Seeking Stability? These 3 Stocks Offer Strong Potential
- How to Invest in Small Cap Stocks
- Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up
Receive News & Ratings for NEXGEL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NEXGEL and related companies with MarketBeat.com's FREE daily email newsletter.
